Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: a plea for multimodal immune modulating therapy in the respiratory insufficient patient

BACKGROUND: The FOLFOX regimen, i.e., folinic acid (FOL), fluorouracil (F) and oxaliplatin (OX), is a drug cocktail that is used to treat gastric and colorectal cancers. Despite the concomitant improvements in response rate, duration of response and patient survival, reports of serious toxic pulmona...

Descripción completa

Detalles Bibliográficos
Autores principales: De Weerdt, Annick, Dendooven, Amélie, Snoeckx, Annemie, Pen, Jan, Lammens, Martin, Jorens, Philippe G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576105/
https://www.ncbi.nlm.nih.gov/pubmed/28851379
http://dx.doi.org/10.1186/s12885-017-3576-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576105/
https://www.ncbi.nlm.nih.gov/pubmed/28851379
http://dx.doi.org/10.1186/s12885-017-3576-y

Ejemplares similares